Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation

被引:78
|
作者
Gao, Yuan [1 ]
Zu, Hui [1 ]
Zhang, Jianjun [1 ]
机构
[1] China Pharmaceut Univ, Sch Pharm, Nanjing 210009, Peoples R China
关键词
adefovir dipivoxil; cocrystal; dissolution; saccharin; stability; CRYSTAL; SACCHARIN; PRODRUGS; KINETICS;
D O I
10.1111/j.2042-7158.2010.01246.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives The objectives of this study were to prepare and characterize the novel adefovir dipivoxil-saccharin cocrystal and to demonstrate the enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation. Methods Adefovir dipivoxil-saccharin cocrystal was prepared using a novel solution crystallization approach and scaled up to 30 g for subsequent studies. DSC, IR and XRPD were used to characterize the novel solid form. The stoichiometry of the cocrystal was analysed by HPLC. Dissolution and chemical stability were assessed and compared with marketed adefovir dipivoxil (form 1) used in marketed Hepsera Tablets. Key findings A new solid adefovir dipivoxil-saccharin cocrystal with unique melting point, DSC, FTIR and XRPD data was obtained. The molar ratio of adefovir dipivoxil and saccharin in the cocrystal was determined to be 1 : 1. The cocrystal had a pH-independent dissolution profile and showed a two-fold increase in the dissolution efficiency in water and phosphate buffer (pH 6.8) compared with adefovir dipivoxil. The cocrystal was kinetically much more stable than form 1. Form 1 degraded almost completely at 60 degrees C in 18 days, while adefovir dipivoxil-saccharin cocrystal remained unchanged for 47 days at 60 degrees C. Conclusions This study demonstrated that the dissolution and stability of adefovir dipivoxil could be significantly enhanced by its cocrystal formation with saccharin. The use of cocrystals could be a feasible and valuable approach for improving the physicochemical properties of adefovir dipivoxil.
引用
收藏
页码:483 / 490
页数:8
相关论文
共 50 条
  • [41] Impact of cocrystal solution-state stability on cocrystal dissociation and polymorphic drug recrystallization during dissolution
    Xuan, Bianfei
    Chen, Yu Chee Sonia
    Wong, Kong Ching
    Chen, Ruipeng
    Lo, Po Sang
    Lakerveld, Richard
    Tong, Henry Hoi Yee
    Chow, Shing Fung
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 610
  • [43] Treatment of patients with chronic hepatitis B with adefovir dipivoxil
    Tong, MJ
    Tu, SS
    SEMINARS IN LIVER DISEASE, 2004, 24 : 37 - 44
  • [44] Adefovir dipivoxil (ADV) for the treatment of chronic HBV infection
    Brosgart, C
    Fry, J
    Xiong, S
    Wulfsohn, M
    Gibbs, C
    Toole, J
    Bischofberger, N
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A82 - A82
  • [45] Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma
    Zhong, Jian Hong
    Li, Le Qun
    Wu, Liu Cheng
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [46] Modeling of Autocatalytic Hydrolysis of Adefovir Dipivoxil in Solid Formulations
    Dong, Ying
    Zhang, Yan
    Xiang, Bingren
    Deng, Haishan
    Wu, Jingfang
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (04): : 643 - 654
  • [48] Adefovir dipivoxil: review of a novel acyclic nucleoside analogue
    Danta, M
    Dusheiko, G
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (09) : 877 - 886
  • [49] Resistance to adefovir dipivoxil in patients with chronic hepatitis B
    Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (1): : 4 - 4
  • [50] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment
    You, J.
    Zhuang, L.
    Chen, H. Y.
    Feng, X.
    Kong, L.
    Lei, H.
    Ma, Y. L.
    Li, Y. L.
    Yang, W. B.
    Huang, J. H.
    Yan, S. M.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S30 - S30